Transitioning to Dolutegravir in a Programmatic Setting: Virological Outcomes and Associated Factors Among Treatment-Naive Patients With HIV-1 in the Kilombero and Ulanga Antiretroviral Cohort in Rural Tanzania.

Ntamatungiro, Alex J; Eichenberger, Anna; Okuma, James; Vanobberghen, Fiona; Ndege, Robert; Kimera, Namvua; Francis, Joel M; Kagura, Juliana; Weisser, Maja

Ntamatungiro, Alex J; Eichenberger, Anna; Okuma, James; Vanobberghen, Fiona; Ndege, Robert; Kimera, Namvua; Francis, Joel M; Kagura, Juliana; Weisser, Maja.

Afiliação

Ntamatungiro AJ; Division of Epidemiology and Biostatistics, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Eichenberger A; Department of Interventions and Clinical Trials, Ifakara Health Institute, Ifakara, Tanzania.
Okuma J; Department of Infectious Diseases, Bern University Hospital, Bern, Switzerland.
Vanobberghen F; Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Ndege R; Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Kimera N; University of Basel, Basel, Switzerland.
Francis JM; Division of Epidemiology and Biostatistics, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Kagura J; Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Weisser M; University of Basel, Basel, Switzerland.

Open Forum Infect Dis ; 10(7): ofad321, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37520425

Palavras-chave

ART-naive; HIV-1; dolutegravir; drug resistance; sub-Saharan Africa

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: África do Sul

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google